Tofacitinib, an oral Janus kinase inhibitor, in patients from Colombia with rheumatoid arthritis: Pooled efficacy and safety analyses of data from phase III studies

Authors:
  • PVPatricia Vélez
    Patricia Vélez
  • JJJuan J. Jaller
    Juan J. Jaller
  • WEWilliam J. Otero Escalante
    William J. Otero Escalante
  • EGErika G. García
    Erika G. García
  • RRRicardo Rojo
    Ricardo Rojo
  • DCDouglass Chapman
    Douglass Chapman
  • KPKatherine Persand
    Katherine Persand
  • GMGiovanna A. Matiz
    Giovanna A. Matiz

Abstract
No abstract available

This publication has 35 references indexed in Scilit: